Fatigability in Spinal Muscular Atrophy - Fatigability in SMA

niversitair Medisch Centrum Utrecht0 个研究点目标入组 125 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•1) Genetically confirmed diagnosis of SMA type 2 or type 3 or type 4 (study group) or
•Genetically conformed diagnosis of other neuromuscular disease without neuromuscular junction dysfunction (patient control group) or healthy subject (healthy control group)
•2) Ability to follow test instructions
•3) Parental informed consent/ Inform consent
•4) Age 8-60 years

•- Concomitant medical problems that might intervene with the outcomes of the testing:
•Prior to the first test, all subjects will fill out the Preparticipation Questionnaire. This questionnaire is based on the original version designed by the American College of Sports Medicine and American Heart Association. The Dutch version is currently being used by the Child Development and Exercise Center and the Department of Cardiology during standard care procedures such as Cardio Pulmonary Exercise Testing. In the case of possible risk factors for exercise testing, the researcher will contact the medical specialist or general practitioner of the subject about the possibility to participate before the subject is included

发起方

niversitair Medisch Centrum Utrecht